Since the establishment of reverse genetics techniques to manipulate the influenza virus genome, it has been possible to study viral molecular signatures responsible for virulence, and the generation of novel and improved vaccine strains. Moreover, high throughput screen technologies combined with functional genomics, transcriptomics and proteomics are now been used to identify novel mechanisms associated with virus replication and pathogenicity, as well as novel antivirals. Finally recombinant technologies can now be applied for the generation of broadly neutralizing influenza virus vaccines that could eliminate the need for annual vaccination and prevent pandemics by inducing protective immunity against conserved epitope shared by all influenza virus strains.
Learning objectives:
1. Current influenza vaccines and antivirals are useful, but not optimal
2. New technologies allow the discovery of improved influenza antivirals and vaccines
Molecular Biology
Laboratory Testing
Clinical Diagnostics
Pcr/rt-Pcr/real-Time Pcr
Microbiology
Immunology
Gene Expression
Gene Sequencing
Dna
Infectious Disease
Cancer Research
Dna Sequencing
Cell Biology
Molecular Diagnostics
Diagnostics
North America53%
Asia37%
Europe5%
Website Visitors89%
Email Promotions11%
Medical Laboratory Technician33%
Student13%
Educator/Faculty13%
Research Scientist13%
Lab Management13%
Clinical Laboratory Scientist7%
Veterinarian7%
Academic Institution42%
Hospital11%
Clinical Laboratory11%
Veterinary School5%
Medical School5%
Medical Center5%
Government5%
Diagnostic Company5%
Other5%